Geriatric assessment practices in oncology: A survey of Australian clinicians [0.03%]
澳大利亚肿瘤学临床医生的姑息治疗实践调查
Antonina Obayo,Francine Antoinette Ocampo,Baldwin Lau et al.
Antonina Obayo et al.
Brentuximab vedotin and dose attenuated chemoimmunotherapy for patients 75 years and older with diffuse large B-cell lymphoma with analysis of outcomes by frailty [0.03%]
Brentuximab Vedotin及减量化疗免疫治疗治疗弥漫大 B 细胞淋巴瘤老年患者（≥75 岁）及其虚弱结局分析
Patrick M Reagan,Allison Magnuson,Craig A Portell et al.
Patrick M Reagan et al.
Introduction: Dose attenuated rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-miniCHOP) is a curative-intent regimen that balances safety and efficacy in older patients with diffuse large B-cell l...
Less treatment, but whose choice? Geriatric considerations in breast cancer care [0.03%]
少治疗，但自主选择吗？——乳腺癌患者老年综合评估专家共识
Mohammad Shkokani,Louis John Koizia,Benjamin Howell Lole Harris
Mohammad Shkokani
Letter to the editor: Cardiovascular and cancer-specific mortality in older patients with advanced non-small cell lung cancer following the introduction of immuno-oncology therapies [0.03%]
致编辑的信：免疫-肿瘤学疗法的应用对老年晚期非小细胞肺癌患者的心血管和癌症特异性死亡率的影响
Sari Luthfiyah,Ach Arfan Adinata,Joylyn L Mejilla et al.
Sari Luthfiyah et al.
Barriers and facilitators of deprescribing for older adults with cancer and polypharmacy [0.03%]
老年人癌症多药治疗减药的障碍与促进因素
Kofi Gyasi Agyei,Arul Malhotra,Sally A Norton et al.
Kofi Gyasi Agyei et al.
Introduction: Polypharmacy affects up to 93% of older adults with cancer and increases risks of treatment toxicity, drug interactions, and adverse outcomes. Deprescribing, the planned discontinuation of potentially inappr...
Comment on "Effect of geriatric co-management on independence, quality of life, and severe toxicity in vulnerable older patients with cancer: Results of a randomized clinical trial" [0.03%]
关于老年共管对脆弱老年癌症患者独立性、生活质量及严重毒性影响的评论：一项随机临床试验的结果
Daniel Sibley,Adeline Gonzales,Martine Puts
Daniel Sibley
Nursing practice in cancer treatment decision making among older adults: A scoping review on behalf of the International Society of Geriatric Oncology Nursing, Allied Health, and Scientists Interest Group [0.03%]
国际老年肿瘤学会护理、 allied health 和科学家兴趣小组的癌症治疗决策行为综述：老年人的护理实践
Fay J Strohschein,Hanneke van der Wal-Huisman,K Alix Hayden et al.
Fay J Strohschein et al.
Introduction: Cancer treatment decision making (CTDM) presents important challenges among older adults due to variation in health and functional status, presence of comorbidities, differing goals/values, quality and quant...
Geriatric oncology in 2040: Exploring potential realities and challenges. A diverse perspective [0.03%]
2040年的老年肿瘤学：探讨潜在现实与挑战。多样性的视角
Raymond Gardner,Luciola Pontes Leite de Barros,Kwok Leung Cheung et al.
Raymond Gardner et al.
The average global life expectancy is predicted to increase to approximately 80 years by 2040 [1]. Cancer is an ageing-related disease, and its prevalence will also increase with this ageing of the population [2]. This rise in older adults ...